Image of sand pouring down an hourglass

It's About Time

After decades, a new neuromodulator category has arrived. DAXXIFY® is the first and only peptide-powered, FDA-approved frown line treatment with a median duration of 6 months.1-9*

Learn More

DAXXIFY® is What Your Patients are Looking For

Conventional frown line treatments last a median of approximately 3-4 months.5-7,10

Nearly 90% of patients want a longer-lasting treatment.10
Most patients get fewer than 2 neuromodulator treatments a year.10
Patients are left untreated for 4-6 months of the year.5-7,10

Do your patients want more time with less lines?

Get Started
Image of vial of product

Long Lasting

DAXXIFY® may last up to twice as long as conventional neuromodulator treatments for some patients.2-9*

Review Data
Image of a peptide
Image of a wireframe peptide


Disruptive innovation powered by Peptide Exchange Technology(PXT).2,11 Discover the first neuromodulator of its kind in over 20 years.1,2,5-8

Learn More

Outstanding Results

Give your patients a look that lasts.3

See Results

Offer DAXXIFY® to Your Patients

Learn how to order today.

Get Started